---
figid: PMC6328535__41598_2018_37188_Fig6_HTML
figlink: /pmc/articles/PMC6328535/figure/Fig6/
number: Figure 6
caption: Dacarbazine and PLX4032 cross-resistance emerges via distinct MAPK-dependent
  and -independent pathway activation. Canonical and oncogenic MAPK and PI3K/AKT/mTOR
  signalling in (A) parental, sensitive BRAFV600E melanoma cells, (B) dacarbazine-resistant
  BRAFV600E melanoma cells that show cross-resistance to vemurafenib (PLX4032) and
  (C) PLX4032-resistant BRAFV600E melanoma cells that have cross-resistance to dacarbazine.
  BRAFV600E affected, hyperactivated kinases are marked in red, dacarbazine- and PLX4032-affected
  molecular targets of resistance emergence are marked in green and blue, respectively.
  GPCR = G-protein-coupled receptor, RTK = receptor tyrosine kinase, GFs = growth
  factors.
pmcid: PMC6328535
papertitle: Induced cross-resistance of BRAFV600E melanoma cells to standard chemotherapeutic
  dacarbazine after chronic PLX4032 treatment.
reftext: Sarah Erdmann, et al. Sci Rep. 2019;9:30.
pmc_ranked_result_index: '61619'
pathway_score: 0.9443591
filename: 41598_2018_37188_Fig6_HTML.jpg
figtitle: Dacarbazine and PLX4032 cross-resistance emerges via distinct MAPK-dependent
  and -independent pathway activation
year: '2019'
organisms:
- Homo sapiens
ndex: ''
annotations: []
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6328535__41598_2018_37188_Fig6_HTML.html
  '@type': Dataset
  description: Dacarbazine and PLX4032 cross-resistance emerges via distinct MAPK-dependent
    and -independent pathway activation. Canonical and oncogenic MAPK and PI3K/AKT/mTOR
    signalling in (A) parental, sensitive BRAFV600E melanoma cells, (B) dacarbazine-resistant
    BRAFV600E melanoma cells that show cross-resistance to vemurafenib (PLX4032) and
    (C) PLX4032-resistant BRAFV600E melanoma cells that have cross-resistance to dacarbazine.
    BRAFV600E affected, hyperactivated kinases are marked in red, dacarbazine- and
    PLX4032-affected molecular targets of resistance emergence are marked in green
    and blue, respectively. GPCR = G-protein-coupled receptor, RTK = receptor tyrosine
    kinase, GFs = growth factors.
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - AKT3
  - MAP2K2
  - AKT2
  - CROT
  - AKT1
  - MAPK3
  - NMUR1
  - MTOR
  - MAPK1
  - PIK3R3
  - MAP2K1
  - BRAF
  - RAF1
  - NRAS
  - PIK3CA
  - PIK3CB
  - PIK3CD
  - PIK3R5
  - PIK3R4
  - PIK3CG
  - PIK3R6
  - dacarbazine
  - PLX4032
  - vemurafenib
  - dacarbazine H
  - Cancer
genes:
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT3
  entrez: '10000'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K2
  entrez: '5605'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT2
  entrez: '208'
- word: COT
  symbol: COT
  source: hgnc_alias_symbol
  hgnc_symbol: CROT
  entrez: '54677'
- word: AKT
  symbol: AKT
  source: bioentities_symbol
  hgnc_symbol: AKT1
  entrez: '207'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK3
  entrez: '5595'
- word: GPCR
  symbol: GPC-R
  source: hgnc_alias_symbol
  hgnc_symbol: NMUR1
  entrez: '10316'
- word: mTOR
  symbol: MTOR
  source: hgnc_symbol
  hgnc_symbol: MTOR
  entrez: '2475'
- word: ERK
  symbol: ERK
  source: bioentities_symbol
  hgnc_symbol: MAPK1
  entrez: '5594'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R3
  entrez: '8503'
- word: MEK
  symbol: MEK
  source: bioentities_symbol
  hgnc_symbol: MAP2K1
  entrez: '5604'
- word: BRAF
  symbol: BRAF
  source: hgnc_symbol
  hgnc_symbol: BRAF
  entrez: '673'
- word: CRAF
  symbol: c-Raf
  source: hgnc_alias_symbol
  hgnc_symbol: RAF1
  entrez: '5894'
- word: NRAS
  symbol: NRAS
  source: hgnc_symbol
  hgnc_symbol: NRAS
  entrez: '4893'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CA
  entrez: '5290'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CB
  entrez: '5291'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CD
  entrez: '5293'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R5
  entrez: '23533'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R4
  entrez: '30849'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3CG
  entrez: '5294'
- word: PI3K
  symbol: PI3K
  source: bioentities_symbol
  hgnc_symbol: PIK3R6
  entrez: '146850'
chemicals:
- word: dacarbazine
  source: MESH
  identifier: D003606
- word: PLX4032
  source: MESH
  identifier: C551177
- word: vemurafenib
  source: MESH
  identifier: C551177
- word: dacarbazine H
  source: MESH
  identifier: D003606
diseases:
- word: Cancer
  source: ''
  identifier: ''
---
